Global Orthopedic Soft Tissue Repair Market

Orthopedic Soft Tissue Repair Market Size, Share, Growth Analysis, By Application(Rotator Cuff Repair, Epicondylitis), By Injury Location(Knee, Shoulder) - Industry Forecast 2024-2031


Report ID: SQMIG35A2582 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 70 | Figures: 65

Orthopedic Soft Tissue Repair Market Insights

Global Orthopedic Soft Tissue Repair Market size was valued at USD 6.60 billion in 2022 and is poised to grow from USD 7.15 billion in 2023 to USD 13.53 billion by 2031, growing at a CAGR of 8.3% in the forecast period (2024-2031).

The adoption and affordability of available treatment avenues are projected to be influential drivers of market expansion. Notably, the Global Burden of Diseases (GBD) study conducted in 2017 highlighted musculoskeletal injuries as contributing to 16% of all years lived with disability, positioning it as the leading contributor to the global disability index.

Conversely, the hip application segment is poised to exhibit the swiftest growth, boasting a CAGR of 8.8% over the forecast period. This remarkable growth can be attributed to the escalating occurrence of hip joint dysfunction triggered by soft tissue injuries. Such injuries surrounding the hip joint can lead to impaired joint functionality. Recent focus areas in hip pathology encompass concerns like hip impingement and labral tears. With an increasing prevalence of conditions such as labral tears, chondral damage, and ligamentum teres lesions in deep hip soft tissues that are not effectively treatable through physiotherapy alone, this segment has garnered considerable attention. Consequently, market players are being spurred to innovate novel devices and therapies to cater to the demand for more effective treatment solutions.

US Orthopedic Soft Tissue Repair Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Orthopedic Soft Tissue Repair Market size was valued at USD 6.60 billion in 2022 and is poised to grow from USD 7.15 billion in 2023 to USD 13.53 billion by 2031, growing at a CAGR of 8.3% in the forecast period (2024-2031).

The competitive landscape of the orthopedic soft tissue repair market is marked by intense rivalry among key players striving to establish their prominence. Leading medical device companies are engaged in strategic initiatives such as mergers, acquisitions, collaborations, and partnerships to expand their product portfolios and geographical presence. These players focus on continuous research and development to introduce innovative and technologically advanced soft tissue repair solutions, enhancing patient outcomes. 'Arthrex, Inc. (United States)', 'Johnson & Johnson (United States)', 'Smith & Nephew plc (United Kingdom)', 'Stryker Corporation (United States)', 'Medtronic plc (Ireland)', 'Zimmer Biomet Holdings, Inc. (United States)', 'CONMED Corporation (United States)', 'DePuy Synthes (United States)', 'Ceterix Orthopaedics (United States)', 'ArthroCare Corporation (United States)'

The increasing prevalence of sports-related injuries, trauma cases, and degenerative musculoskeletal conditions is driving the demand for effective soft tissue repair solutions.

Minimally Invasive Procedures: Increasing preference for minimally invasive surgical techniques for orthopedic soft tissue repair is a prominent trend. Patients and surgeons alike are opting for procedures that offer quicker recovery, reduced postoperative pain, and shorter hospital stays.

In 2022, North America held the predominant market share of 45.0%, primarily influenced by the escalating number of knee arthroscopies conducted within the region. Notably, an article published by the Osteoarthritis Research Society International revealed that out of the annual 1 million knee arthroscopies performed in the United States, a substantial 700,000 involved meniscus procedures. The region's growth is further propelled by the augmentation of healthcare expenditure and investments in healthcare infrastructure. Increased healthcare spending plays a pivotal role in rendering costly orthopedic soft tissue repair surgeries more accessible. For instance, data from the National Health Expenditure (NHE) study conducted by KFF elucidated that the total national health expenditure in the U.S. surged from USD 3,178 billion in 2015 to USD 3,795 billion in 2019.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Orthopedic Soft Tissue Repair Market

Product ID: SQMIG35A2582

$5,300
BUY NOW GET FREE SAMPLE